Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
104.83
+1.20 (1.16%)
Feb 21, 2025, 4:00 PM EST - Market closed
Zimmer Biomet Holdings Revenue
In the year 2024, Zimmer Biomet Holdings had annual revenue of $7.68B with 3.85% growth. Zimmer Biomet Holdings had revenue of $2.02B in the quarter ending December 31, 2024, with 4.28% growth.
Revenue (ttm)
$7.68B
Revenue Growth
+3.85%
P/S Ratio
2.77
Revenue / Employee
$426,589
Employees
18,000
Market Cap
20.87B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 7.68B | 284.40M | 3.85% |
Dec 31, 2023 | 7.39B | 454.30M | 6.55% |
Dec 31, 2022 | 6.94B | 112.60M | 1.65% |
Dec 31, 2021 | 6.83B | 699.80M | 11.42% |
Dec 31, 2020 | 6.13B | -1.85B | -23.24% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
ZBH News
- 15 days ago - Zimmer Biomet: Adding To The Growth Profile - Seeking Alpha
- 15 days ago - Why Is Zimmer Biomet Stock Trading Lower On Thursday? - Benzinga
- 15 days ago - Zimmer Biomet Holdings, Inc. (ZBH) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Zimmer Biomet forecasts 2025 profit below estimates - Reuters
- 21 days ago - ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Paragon 28, Inc. - PRNewsWire
- 23 days ago - PARAGON 28 INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Paragon 28, Inc. - FNA - Business Wire
- 24 days ago - Zimmer Biomet to buy Paragon 28 for $1.1 billion - Reuters
- 5 weeks ago - Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2024 Financial Results - PRNewsWire